baber/WOPTO huggingface dataset:
Patent CA-2614414-A1 (CA)
Title: Ngl recovery methods and configurations
Inventor: GRAHAM CURT
IPC: F25J3/00
Filed: 2006-02-07
Abstract: Contemplated plants and methods for NGL recovery from feed gases having a carbon dioxide content equal or greater than about 2% employ temperature control configurations that allow high-level and flexible recovery of ethane and heavier components while avoiding freezing of the carbon dioxide in the process. Where the feed gas has a significant fraction of C3+ components and moderate carbon dioxide content, a single column configuration with an intermediate reflux condenser may be used, while two-column configurations may be used for feed gases with high carbon dioxide content and relatively low C3+  component concentration.
Patent CA-2614941-A1 (CA)
Title: Method for detecting peptides comprising a cross-beta structure
Inventor: GEBBINK MARTIJN FRANS BEN GERA
IPC: C07K14/765
Filed: 2006-07-13
Abstract: The invention relates to the field of aqueous solutions comprising a protein.  More specifically, the invention relates to the detection and/or removal of conformationally altered proteins and/or peptides comprising a cross-~  structure from an aqueous solution comprising a protein. The invention provides methods for detecting and/or removing proteins and/or peptides comprising a cross-~ structure from an aqueous solution comprising a protein, said method comprising contacting said aqueous solution comprising a protein with at least one cross-~ structure-binding compound resulting in a bound protein or peptide with cross-~ structure. The invention further provides a aqueous solution comprising a protein obtainable by a method of the invention, and a kit for carrying out the methods of the invention.
Patent CA-2619309-A1 (CA)
Title: Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
Inventor: GREENFIELD ALEXANDER ALEXEI
IPC: C07D403/12
Filed: 2006-08-08
Abstract: The present invention provides a compound of formula (I) and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
Patent CA-2620088-A1 (CA)
Inventor: ROHART EMMANUEL
IPC: B01D53/86
Filed: 2006-09-08
Abstract: L'invention concerne un procédé de traitement d'un gaz contenant des oxydes d'azote (NOx) qui est caractérisé en ce qu'on utilise comme piège à NOx une composition à base d'un catalyseur d'oxydation des NOx en NO2 et d'un composé à base d'oxyde de zirconium et d'oxyde de praséodyme dans une proportion d'oxyde de praséodyme comprise entre 5 % et 50 % en poids d'oxyde. Ce composé peut comprendre en outre de l'oxyde de cérium. Le procédé de l'invention peut être utilisé dans le traitement de gaz d'échappement de moteur à combustion interne de type Diesel ou de type essence fonctionnant en mélange pauvre.
Patent CA-2621613-A1 (CA)
Inventor: KITTAKA EIJI
IPC: F16H3/083
Filed: 2008-02-13
Abstract: To prevent an increase in the diameter of a shift drum and eliminate the significant change of the shape of a lead groove even if the number of shift positions set on the shift drum is increased. A shift drum is provided on the outer circumference thereof with at least one particular lead groove among lead grooves which continuously extends beyond one circle of the shift drum and with both ends of the second lead groove which are arranged so as to be out of alignment with each other in the axial direction of the shift drum. A  common shift position adapted to establish gear trains with two shift stages different from each other is set at one position corresponding to both the ends of the particular lead groove along the circumferential direction of the shift drum.
Patent CA-2622245-A1 (CA)
Inventor: SVANAS GALEN TANNER
IPC: A63F9/24
Filed: 2006-08-30
Abstract: A method displays a number of symbol locations (40 1-4 10) with a respective graphic symbol at each symbol location. This group of presentation symbols includes a target symbol (41 1 ). In response to a first player input, each of the number of symbol locations (401-410) is caused to conduct a respective symbol change process (303) one or more times to change the graphic symbol included at each respective symbol location (401-410) to a respective one of the graphic symbols included in the group of presentation symbols. According to the invention, at least some of the awards available in the game are based at least in part on the absence of the target symbol (41 1 ) at one or more of the number of symbol locations.
Patent CA-2625646-A1 (CA)
Title: Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension
Inventor: HASEGAWA PHILIP A
IPC: A61K38/00
Filed: 2006-10-20
Abstract: The present invention relates to pharmaceutical compositions comprising a combination of a particular dipeptidyl peptidase-4 (DPP-4) inhibitor and an anti-hypertensive agent selected from the group consisting of an angiotensin II receptor antagonist and an angiotensin converting enzyme inhibitor, kits containing such combinations and methods of using such compositions for the treatment of diabetes, diabetes-related disorders, hypertension, and hypertension-related disorders.
Patent CA-2626324-A1 (CA)
Title: Arylurea derivatives as modulators of chemokine receptor activity
Inventor: LEHR PHILIPP
IPC: C07D233/54
Filed: 2006-10-23
Abstract: A compound of formula (I), wherein substituents are as given above, useful in the treatment of a disease mediated by the action of CCR3, in particular inflammatory or obstructive airway diseases.
Patent CA-2627266-A1 (CA)
Title: Liquid container with liquid amount detection unit and liquid filling method
Inventor: KIMURA HITOTOSHI
IPC: G01F23/296
Filed: 2006-11-07
Abstract: A liquid container (1) includes: a liquid containing portion (7) that is pressurized by a pressure unit and discharges a liquid stored therein through a liquid discharge port (7b) ; a liquid supply port (9) that supplies the liquid to an external liquid consuming apparatus; and a liquid detection unit (11) interposed between the liquid containing portion and the liquid supply port. The liquid detection unit includes: a liquid detection chamber (21) having a liquid inlet port (lla) connected to the liquid discharge port and a liquid outlet port connected to the liquid supply port; a movable member (127) that is movable in response to a liquid amount of the liquid detection chamber; a recess portion (19a) that partitions a detection space in cooperation with one surface of the movable member when the liquid amount of the liquid detection chamber becomes a predetermined amount or less, and a piezoelectric detection unit (35) that applies vibration to the recess portion and detects a free vibration state according to the applied vibration. The movable member comprises two flow passages (127a, 127b) that connect the detection space to the liquid detection chamber.
Patent CA-2627945-A1 (CA)
Inventor: LEIGH STEVE
IPC: G01N33/15
Filed: 2006-11-10
Abstract: There are described solid compositions or examining drug solubility comprising bile salts and phospholipids, optionally containing buffer components suitable for preparation of intestinal media that simulate the composition of the intestinal fluids in fasted and fed states.
Patent CA-2628667-A1 (CA)
Title: 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
Inventor: KNUST HENNER
IPC: C07D413/06
Filed: 2006-10-27
Abstract: The present invention is concerned with 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives of formula (I) wherein R1 is hydrogen or halogen; R2 is hydrogen, halogen, hydroxy, lower alkoxy, OCF3, -OCH2-R, R3 is hydrogen or lower alkoxy;  or R2 and R3 form together with the carbon atom to which they are attached a ring with -CH=CH-CH=-CH-; R is aryl or heteroaryl, optionally substituted by halogen or lower alkyl, or is C(O)NH-lower alkyl, or is -C(O)-heteroaryl, wherein the heteroaryl group is optionally substituted by lower alkyl or phenyl, and with their pharmaceutically acceptable acid addition salts. It has been found that this class of compounds show high affinity and selectivity for GABA A cc5 receptor binding sites and might be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease.
Patent CA-2633237-A1 (CA)
Inventor: CHUNG KOON FOR
IPC: B25F5/00
Filed: 2008-06-03
Abstract: A hand operated router having a base, with a portion that is transparent. Disposed within the base is at least one light emitting source, where the light emitting source is designed to partially emit light towards a workpiece. The light emitting source may be battery operated or may receive power from the same source as the router.
Patent CA-2636272-A1 (CA)
Inventor: CVETANOVIC MIODRAG
IPC: A61F5/41
Filed: 2007-01-18
Abstract: A harness for generating an elongation of the penis comprises a belt (1), adapted to be worn around one's waist, connected at the rear portion via small rotating snap-hooks with two inextensible cinching straps (8,15), said straps each having a pair of half-rings (9,16) for length adjustment. One said strap (8) on lower end carrying adjustable rope loop (13) to be placed around penis base. Second said strap (15) on lower end is connected via L-shaped connecting member (17) with flexible adjustable loop (19) being encircled and tightened around penis next to the penis head. Penis stretching force is easily and quickly managed by tightening or loosening said straps, even while walking and even over the clothing.
Patent CA-2637088-A1 (CA)
Title: A method of providing context aware announcements
Inventor: TRINH TRUNG TIM
IPC: H04L12/66
Filed: 2008-07-03
Abstract: A method and system of providing context aware announcements is provided.  Context call handling rules are applied to determine a current context of an incoming call.  At least one context aware announcement is provided for providing information associated the current context and call information.
Patent CA-2637281-A1 (CA)
Inventor: DEOLDEN JAMES
IPC: A61K35/39
Filed: 2006-10-31
Abstract: The present invention relates to methods for improving the viability and recovery of islets that are separated from a donor organ for subsequent transplantation. Tn a preferred embodiment, the islets are separated from a donor pancreas and trans-planted into the liver of a diabetic patient. A protective agent is mixed with a separating solution to form a protective separating solution which is utilized to separate the islets cells from other cells after the donor pancreas is digested with an enzyme. The protective agent increases the viscosity of the solution during the separation process, creating a cushioning effect of islets, thereby enhancing their viability and health so that the islets' membranes may withstand a vigorous isolation procedure such as the Edmonton Protocol.
Patent CA-2638509-A1 (CA)
Inventor: MCGUFFIN THOMAS F
IPC: B64D47/02
Filed: 2008-08-05
Abstract: Methods and apparatus' for operating a communication system between an aircraft and a communication center are provided. One method includes using an aircraft communication addressing and reporting system (ACARS) of an aircraft to control a gatelink communication system of the aircraft.
Patent CA-2639815-A1 (CA)
Inventor: FAUST DIRK
IPC: B66C23/90
Filed: 2006-12-19
Abstract: The invention relates to a control and regulation device for safeguarding a conveyor device (1), in particular, a crane unit in the case of overload. A  brake device (11, 18) acting on the conveyor device (1) is provided, along with a controller (30) for the brake device (11, 18), an overload sensor (29), recording the overload and emitting an overload signal and a speed sensor (31, 24), recording a conveyed item speed and emitting a speed signal. The controller (30) reacts to the overload signal on the braking device (11, 18), such that this device stops the conveyor device and thus safeguards a conveyed item (16). On a subsequent unload signal the controller (30) releases the conveyor device (1) such that the conveyor device (1) is moved into an unload position by the effect of the load of the conveyed item (16) and the effect of the braking device (11, 18) on the conveyor device (1) is regulated according to the speed signal from the speed sensor (24, 31) such that the conveyed item (16) is moved into the unload state at an essentially constant conveyor speed.  The invention further relates to a conveyor device with such a control and regulation arrangement and a container crane unit with two conveyor devices provided with such a control and regulation device.
Patent CA-2641102-A1 (CA)
Title: Fuel cell consisting of a coolant-gas cooling apparatus
Inventor: ROBERGE GUILLAUME
IPC: H01M8/24
Filed: 2008-10-09
Abstract: The fuel cell has a cooling device to cool a stack (1) of cells by forced heat exchange with a heat transfer gas e.g. air, obtained from a gaseous flow generator (2) e.g. fan, along a flow axis (A). A diffuser insert (3) is arranged between the cell stack and the generator, and has static blades (13) to reduce heterogeneity of the gas flow. The generator has rotating blades (12) connected to a rotating hub (22). The static blades are bent for redirecting a part of the gas flow moved away from the axis towards a zone of the flow closer to the axis, where the axis passes via the hub.
Patent CA-2643098-A1 (CA)
Inventor: HERZOG STEVEN NEILL
IPC: C10M171/02
Filed: 2006-11-21
Abstract: The present invention describes use of a fluid having a VI of at least 130 to improve the en- ergy efficiency of a hydraulic system. Furthermore, the present invention relates to a hy- draulic system comprising a hydraulic fluid having a VI of at least 130, a unit for creating mechanical power, a unit that converts mechanical power into hydraulic energy, and a unit that converts hydraulic energy into mechanical work. Preferentially, engine speed can be reduced to decrease load and stress while delivering the same amount of hydraulic power.
Patent CA-2644933-A1 (CA)
Title: Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions
Inventor: PLATO CRAIG F
IPC: A61P9/00
Filed: 2007-02-26
Abstract: A therapeutic combination, useful in a co-therapy method for improving cardiovascular performance and/or treating cardiovascular diseases, is provided comprising a first agent and a second agent, wherein the first agent comprises a histone deacetylase inhibiting agent and the second agent comprises at least one nuclear hormone receptor ligand.
Patent CA-2645137-A1 (CA)
Title: Heterobicyclic pyrazole compounds and methods of use
Inventor: TIAN HONGQI
IPC: A61K31/437
Filed: 2007-03-06
Abstract: Compounds of Formulas (Ia) and (Ib), and stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting receptor tyrosine kinases and for treating disorders mediated thereby. Methods of using compounds of Formula Ia and Ib, and stereoisomers, geometric isomers, tautomers, solvates and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
Patent CA-2646032-A1 (CA)
Inventor: KIM JIN SEOP
IPC: B62D21/18
Filed: 2008-12-09
Abstract: A manual leveling control system and method for construction equipment is provided. The manual leveling control system for construction equipment includes a swing angle sensing unit sensing a swing angle of an upper swing frame and transmitting a signal for the sensed swing angle; a tilting manipulation input unit generating and transmitting a tilting manipulation signal corresponding to coordinate values on a coordinate system, having coordinate axes corresponding to left/right direction and front/rear direction of the upper swing frame, in accordance with a position manipulated by a user; and a control unit determining target actuators to be operated among actuators radially positioned around a tilting unit using the coordinate values of the tilting manipulation signal and the swing angle of the upper swing frame, and calculating operation values for determining whether to extend/contract the target actuators and operation ranges of the target actuators, in order to tilt the upper swing frame against a reference surface in accordance with the tilting manipulation signal.
Patent CA-2649184-A1 (CA)
Title: Process for hydrogenating an aldehyde
Inventor: KOMPLIN GLENN CHARLES
IPC: B01J37/02
Filed: 2007-04-11
Abstract: The present invention relates to a process for hydrogenating an aldehyde. An aldehyde is contacted with a catalyst comprising a support containing at least 95% a-alumina and non-support metals dispersed on the surface of the support. The non-support metals comprise nickel and/or one or more compounds thereof and molybdenum and/or one or more compounds thereof. The nickel and/or one or more compounds thereof comprise from 3 wt.% to 9 wt.% of the catalyst, by metallic weight, and the molybdenum and/or one or more compounds thereof comprise from 1 wt.% to 4 wt.% of the catalyst, by metallic weight.
Patent CA-2652210-A1 (CA)
Inventor: JONKER NIELS
IPC: H04W48/16
Filed: 2007-05-14
Abstract: A system and method of network point of access detection and use is disclosed. In accordance with such system and method, suitability of a given wireless network for access and use can be determined. Such system and method are fully-configurable and incrementally-updatable using configuration information. The configuration information, which can include network profiles and scripting functions, can be used to dynamically configure a client device to perform test network points of access, to determine usability status of network points of access, without modifying an underlying operating platform (e.g., an operating software platform) of the client device. The usability status can be cached by a client device and used to facilitate subsequent network detection and to make an informed selection of a network point of access.
Patent CA-2656613-A1 (CA)
Title: Prevention of rash in patients undergoing anti-egfr therapy
Inventor: BAADSGAARD OLE
IPC: A61K39/395
Filed: 2007-07-03
Abstract: The invention relates to a method for the treatment of a disease susceptible to anti-EGFR treatment, comprising the step of administering, to a human being in nee thereof, a combination of an anti-EGFR agent and an anti-neutrophil-chemoattracta agent, wherein said anti-neutrophil-chemoattractant agent is administered in a dosag regimen that is sufficient to reduce one or more undesired dermatological side-effects the anti-EGFR agent. In one embodiment, the anti-EGFR agent is an anti-EGF antibody and the anti-neutrophil-chemoattractant agent is an anti-IL-8 antibody.
Patent CA-2657015-A1 (CA)
Title: Opsin stabilizing compounds and methods of use
Inventor: OSTROV DAVID A
IPC: C07K14/705
Filed: 2007-07-27
Abstract: The present invention provides compositions and methods useful in the treatment and/or prevention of ophthalmic conditions and diseases, such as retinitis pigmentosa, that are dependent upon or related to misfolded opsin proteins in vivo. In addition, screening assays for agents useful in such treatment methods are described.
Patent CA-2658164-A1 (CA)
Inventor: KORNEFF NEIL A
IPC: A61M15/00
Filed: 2007-03-29
Abstract: Various embodiments of a breath-activated nebulizer with fluidic control and related methods of using such a nebulizer are disclosed. The nebulizer (10) may include a body (20) comprising a reservoir (22) for holding medication (30), a nozzle (74) for emitting a jet of pressurized gas, and a fluid conduit (26) in communication with the reservoir for delivery of the medication proximate the jet to produce an aerosol of medication. The nebulizer may also include a nebulizer outlet (29) in communication with an interior (24) of the body for delivery of the aerosol to a patient, a control conduit (77) in fluid communication with the fluid conduit for delivery of a control gas to the fluid conduit to prevent the delivery of the medication proximate the jet, and a fluidic amplifier (54) configured to control the delivery of the control gas to the control conduit.
Patent CA-2659387-A1 (CA)
Inventor: LU WENYUAN
IPC: G01N33/566
Filed: 2007-07-20
Abstract: The present invention is related to compositions useful for the measurement of free or unbound analyte concentrations in a fluid. The present invention includes the use of capture ligands and stabilizing agents to improve the accuracy of analyte concentration assays. Methods and tools for using the present invention are also disclosed.
Patent CA-2659958-A1 (CA)
Inventor: TERREUX RAPHAEL
IPC: G01N33/566
Filed: 2006-08-07
Abstract: Peptides having a sequence of general formula (I), or the retro form thereof, and having an affinity for one or more mammalian protein kinase C-alpha isoforms are provided: X-[(HY-HB)n-linker]m-(HB-HY)2-HB-(HY)m-Z (I) wherein: HY represents a block of 1 to 4 hydrophobic amino acid residues selected from the group of: Ala, GIy, He, Leu, Phe and VaI; HB represents a block of 1 to 4 amino acid residues capable of forming hydrogen bonds selected from the group of: Arg, Asn, Asp, GIu, GIn, Lys and Ser; "linker" represents 1 to 4 Gly residues; n is 1, 2 or 3; m is 0 or 1 ; X represents the N-terminus of the peptide or a modified version thereof, and Z represents the C-terminus of the peptide or a modified version thereof. The peptides can be used as probes, screening agents, targeting agents, purification agents and diagnostic agents.
Patent CA-2663534-A1 (CA)
Title: Retractable ball seat having a time delay material
Inventor: XU YANG
IPC: E21B33/00
Filed: 2007-09-14
Abstract: Retractable ball seats (20) having a housing (12), a seat, and a plug such as a ball (30) are disclosed. The seat has a retracted position that prohibits the ball from passing through the passageway (25) and an expanded position that permits the ball to pass through the passageway. A time delay material, such as a dissolvable material (40), maintains the seat in the retracted position. The time delay material disintegrates, degrades, or dissolves withi a known period of time such that the retractable ball seat can be placed in a desired location in the wellbore and the ball will be released through the passageway within a known period of time.
Patent CA-2663741-A1 (CA)
Title: Perforated bioabsorbable oil film and methods for making the same
Inventor: LABRECQUE ROGER
IPC: A61L31/00
Filed: 2007-09-14
Abstract: A bio-absorbable stand-alone film is derived at least in part from fatty acids. The bio-absorbable stand-alone film can have anti-adhesive, anti-inflammatory, non-inflammatory, and wound healing properties, and can additionally include one or more therapeutic agents incorporated therein. The stand-alone film has one or more perforations or depressions formed therein. Corresponding methods of making the bio- absorbable stand-alone film with one or more perforations or depressions include molding, cutting, carving, puncturing or otherwise suitable methods to create the perforations or depressions in the bio-absorbable stand-alone film. The resulting stand alone film is bio-absorbable.
Patent CA-2666043-A1 (CA)
Inventor: DRIEHUYS BASTIAAN
IPC: A61B5/055
Filed: 2007-10-02
Abstract: Methods and systems for assessing pulmonary gas exchange and/or alveolar- capillary barrier status include using spin echo pulse techniques to generat e at least one 3-D MRI image of 129Xe dissolved in the red blood cell (RBC) and barrier compartments in the gas exchange regions of the lungs of a patie nt.